CJC-1295 with DAC 2mg dosage is a common research question. Learn how the 2mg vial is typically reconstituted, dosed, and studied in peptide research.
The 2mg dosage of CJC-1295 with DAC is most commonly studied as a single weekly injection of 1–2 mg, though research protocols vary. CJC-1295 with DAC is a long-acting growth hormone–releasing hormone (GHRH) analog, and a 2mg vial is typically reconstituted for laboratory research only. It is not FDA-approved for human use, and this article is for informational purposes only.
What Is CJC-1295 With DAC?
CJC-1295 with DAC (Drug Affinity Complex) is a modified form of GHRH. The DAC binds to albumin in the bloodstream, extending the peptide's half-life to roughly 6–8 days. This makes it very different from short-acting versions like CJC-1295 without DAC, also known as Mod GRF 1-29.
Because of the long half-life, CJC-1295 with DAC is studied with infrequent dosing—often once or twice per week. In contrast, short-acting peptides require multiple daily injections. Both forms remain unapproved by the FDA for any human use.
| Feature | CJC-1295 With DAC | CJC-1295 Without DAC |
|---|---|---|
| Half-life | ~6–8 days | ~30 minutes |
| Dosing frequency | 1–2 times per week | 1–3 times per day |
| Typical research dose | 1–2 mg per week | 100–200 mcg per dose |
| FDA approval | Not approved | Not approved |
How to Reconstitute a 2mg Vial
A 2mg vial of CJC-1295 with DAC is usually mixed with 1–2 mL of bacteriostatic water. The concentration you get depends on how much water you add. For example, adding 1 mL gives 2 mg/mL, while adding 2 mL gives 1 mg/mL.
Researchers who ask about cjc-1295 with dac dosage often need to convert milligrams to syringe units. The table below shows common reconstitution volumes and the corresponding draw for different doses.
| Bacteriostatic water added | Concentration | Volume for 0.5 mg | Volume for 1 mg | Volume for 2 mg |
|---|---|---|---|---|
| 1 mL | 2 mg/mL | 0.25 mL | 0.5 mL | 1 mL |
| 2 mL | 1 mg/mL | 0.5 mL | 1 mL | 2 mL |
| 3 mL | 0.67 mg/mL | 0.75 mL | 1.5 mL | 3 mL |
Always use sterile technique and store reconstituted peptide in the refrigerator. Do not assume that any online calculator is accurate for your specific vial.
Common Research Protocols for 2mg Vials
Published animal studies and anecdotal reports describe several dosing schedules for CJC-1295 with DAC. The most frequently cited protocol is 2 mg once per week. Some researchers split the dose into two 1mg injections per week. Others use a lower weekly dose of 1 mg to reduce potential side effects.
When people search for cjc 1295 dac 2mg dosage, they often find these three patterns. No human clinical trial has established an optimal dose, so all protocols remain experimental.
| Protocol | Frequency | Total weekly dose | Notes |
|---|---|---|---|
| Single weekly injection | Once per week | 2 mg | Most common in research literature |
| Split weekly dose | Twice per week | 2 mg (1 mg each) | May smooth out peak effects |
| Lower weekly dose | Once per week | 1 mg | Sometimes used for sensitivity |
| Every 5 days | ~1.4 times per week | ~2.8 mg | Anecdotal, not standard |
CJC-1295 With DAC and Ipamorelin Stacking
Many research protocols combine CJC-1295 with DAC and ipamorelin. The typical cjc-1295 dac with ipamorelin dosage in these studies is 1–2 mg of CJC-1295 DAC per week plus 100–200 mcg of ipamorelin one to three times daily. This combination is thought to target different aspects of growth hormone release.
However, no large human trials have confirmed the safety or effectiveness of this stack. Any discussion of stacking should be limited to laboratory research, not personal use.
What Reddit and Bodybuilding Forums Say
On platforms like Reddit, users frequently discuss cjc-1295 with dac dosage reddit threads. Common themes include weekly 2mg injections, stacking with ipamorelin, and concerns about water retention. In cjc 1295 with dac dosage bodybuilding communities, users often report increased appetite and mild swelling.
These reports are anecdotal and cannot replace clinical evidence. Individual experiences vary widely, and many users do not report side effects accurately. Always treat forum advice with skepticism.
Safety and Legal Status
CJC-1295 with DAC is not approved by the FDA for human use. It is sold as a research chemical only, and its purchase or possession may be restricted in some US states. Reported side effects from animal studies and user anecdotes include injection site reactions, flushing, headache, and water retention.
If you are considering any peptide for health purposes, consult a licensed healthcare professional. This article does not provide medical advice, and self-administration of research chemicals carries serious risks.
Frequently Asked Questions
What is the typical CJC-1295 with DAC 2mg dosage?
The most commonly cited research dosage for a 2mg vial of CJC-1295 with DAC is 1–2 mg per week, often as a single weekly injection. Some protocols split the dose into two 1mg injections per week. No human clinical trial has established an official dose, and the peptide is not FDA-approved for human use.
How do you reconstitute a 2mg vial of CJC-1295 with DAC?
A 2mg vial is typically reconstituted with 1–2 mL of bacteriostatic water. Adding 1 mL yields a concentration of 2 mg/mL, while adding 2 mL yields 1 mg/mL. Always use sterile technique and store the reconstituted peptide in the refrigerator.
Is CJC-1295 with DAC safe for human use?
No, CJC-1295 with DAC is not approved by the FDA for human use and is sold strictly as a research chemical. Reported side effects include injection site reactions, flushing, headache, and water retention. Consult a healthcare professional before using any peptide, and never self-administer research chemicals.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.